Press "Enter" to skip to content

New patent for Salix Pharms drug PLENVU

0
Copyright © DrugPatentWatch. Originally published at New patent for Salix Pharms drug PLENVU

Annual Drug Patent Expirations for PLENVU
Annual Drug Patent Expirations for PLENVU

Plenvu is a drug marketed by Salix Pharms Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has seventy-seven patent family members in thirty-three countries.

The generic ingredient in PLENVU is ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. One supplier is listed for this compound. Additional details are available on the ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Salix Pharms drug PLENVU
Do NOT follow this link or you will be banned from the site!